Diagnosis and Management of Behavioral Issues in Frontotemporal Dementia
暂无分享,去创建一个
[1] M. Mendez,et al. Accuracy of the clinical evaluation for frontotemporal dementia. , 2007, Archives of neurology.
[2] A. Kertesz,et al. A Longitudinal Study of Behavior in Frontotemporal Dementia and Primary Progressive Aphasia , 2004, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.
[3] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[4] Efstathios D. Gennatas,et al. COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures , 2012, Neurology.
[5] K. Rockwood,et al. An International Needs Assessment of Caregivers for Frontotemporal Dementia , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[6] Paul G Shekelle,et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. , 2011, JAMA.
[7] M. Ikeda,et al. Efficacy of Fluvoxamine as a Treatment for Behavioral Symptoms in Frontotemporal Lobar Degeneration Patients , 2004, Dementia and Geriatric Cognitive Disorders.
[8] L. Schneider,et al. Memantine for dementia. , 2006, The Cochrane database of systematic reviews.
[9] J. Cummings,et al. The Neuropsychiatric Inventory , 1997, Neurology.
[10] M. Mendez. Frontotemporal dementia: therapeutic interventions. , 2009, Frontiers of neurology and neuroscience.
[11] G. Kerchner,et al. Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia , 2011, Expert review of neurotherapeutics.
[12] J. Hodges,et al. Frontotemporal dementia and motor neurone disease: Overlapping clinic-pathological disorders , 2009, Journal of Clinical Neuroscience.
[13] H. Duivenvoorden,et al. Frontotemporal Dementia: Behavioral Symptoms and Caregiver Distress , 2004, Dementia and Geriatric Cognitive Disorders.
[14] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[15] J. Neuhaus,et al. An Open-label Study of Memantine Treatment in 3 Subtypes of Frontotemporal Lobar Degeneration , 2009, Alzheimer disease and associated disorders.
[16] M. Swanberg. Memantine for Behavioral Disturbances in Frontotemporal Dementia: A Case Series , 2007, Alzheimer disease and associated disorders.
[17] B L Miller,et al. Alzheimer disease and frontotemporal dementias. Behavioral distinctions. , 1996, Archives of neurology.
[18] J. Mathias,et al. Neurobehavioral differences between Alzheimer's disease and frontotemporal dementia: A meta-analysis , 2010, Journal of clinical and experimental neuropsychology.
[19] S. Srikanth,et al. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia , 2005, Journal of the Neurological Sciences.
[20] Ivan Enrici,et al. Theory of mind ability in the behavioural variant of frontotemporal dementia: An analysis of the neural, cognitive, and social levels , 2010, Neuropsychologia.
[21] Alan A. Wilson,et al. Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia , 2011, Neuropsychiatric disease and treatment.
[22] J. Hodges,et al. The Impact of Dementia Severity on Caregiver Burden in Frontotemporal Dementia and Alzheimer Disease , 2013, Alzheimer disease and associated disorders.
[23] Matthias J. Müller,et al. Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[24] B. Sahakian,et al. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial , 2004, Psychopharmacology.
[25] Jordan Grafman,et al. Distinct Regions of Prefrontal Cortex Mediate Resistance and Vulnerability to Depression , 2008, The Journal of Neuroscience.
[26] P. Panegyres,et al. The clinical differentiation of fronto-temporal dementia from psychiatric disease , 2007, Neuropsychiatric disease and treatment.
[27] Charles DeCarli,et al. Diagnostic Criteria for the Behavioral Variant of Frontotemporal Dementia (bvFTD): Current Limitations and Future Directions , 2007, Alzheimer disease and associated disorders.
[28] J. Neuhaus,et al. Off-Label Medication Use in Frontotemporal Dementia , 2010, American journal of Alzheimer's disease and other dementias.
[29] A. Bava,et al. Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms , 2002, European Neurology.
[30] M. Mendez,et al. Lethal hyperoral behaviour from the Klüver-Bucy syndrome. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[31] D. Delis,et al. Discriminant validity and neuroanatomical correlates of rule monitoring in frontotemporal dementia and Alzheimer's disease , 2008, Neuropsychologia.
[32] N. Herrmann,et al. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. , 2012, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[33] M. Mendez,et al. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[34] Sasha Bozeat,et al. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[35] K. Rankin,et al. Spontaneous social behaviors discriminate behavioral dementias from psychiatric disorders and other dementias. , 2008, The Journal of clinical psychiatry.
[36] T. Robbins,et al. Methylphenidate (‘Ritalin’) can Ameliorate Abnormal Risk-Taking Behavior in the Frontal Variant of Frontotemporal Dementia , 2006, Neuropsychopharmacology.
[37] K. Blennow,et al. Decreased monoamine metabolites in frontotemporal dementia and Alzheimer’s disease , 1998, Neurobiology of Aging.
[38] J R Hodges,et al. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.
[39] F. Verhey,et al. Impact of Behavioural Problems on Spousal Caregivers: A Comparison between Alzheimer’s Disease and Frontotemporal Dementia , 2006, Dementia and Geriatric Cognitive Disorders.
[40] A. Kertesz,et al. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia , 2000, Journal of the International Neuropsychological Society.
[41] Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. , 1997, The Journal of clinical psychiatry.
[42] Hans Förstl,et al. A 6‐month, open‐label study of memantine in patients with frontotemporal dementia , 2008, International journal of geriatric psychiatry.
[43] J. Merrilees. A Model for Management of Behavioral Symptoms in Frontotemporal Lobar Degeneration , 2007, Alzheimer disease and associated disorders.
[44] Olivier Piguet,et al. Eating and hypothalamus changes in behavioral-variant frontotemporal dementia , 2011, Annals of neurology.
[45] M. Laine,et al. Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia , 2002, Neurology.
[46] M. Mendez,et al. Emergent neuroleptic hypersensitivity as a herald of presenile dementia. , 2001, The Journal of neuropsychiatry and clinical neurosciences.
[47] D. Neary,et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. , 2012, Brain : a journal of neurology.
[48] F. Pasquier,et al. Frontotemporal Dementia: A Randomised, Controlled Trial with Trazodone , 2004, Dementia and Geriatric Cognitive Disorders.
[49] J. Bisbe,et al. Use of Antidementia Drugs in Frontotemporal Lobar Degeneration , 2012, American journal of Alzheimer's disease and other dementias.
[50] J. O'Brien,et al. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology , 2011, Journal of psychopharmacology.
[51] A. Kertesz,et al. The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. , 2011, Brain : a journal of neurology.
[52] S. Engelborghs,et al. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease , 2005, International journal of geriatric psychiatry.
[53] J. Shapira,et al. Stereotypical movements and frontotemporal dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.
[54] M. Trabucchi,et al. Alzheimer disease and frontotemporal dementia. , 1997, Archives of neurology.
[55] J. Becker,et al. Symptoms of depression and psychosis in Alzheimer's disease and frontotemporal dementia : Exploration of underlying mechanisms , 1996 .
[56] A. Bava,et al. Rivastigmine in Frontotemporal Dementia , 2004, Drugs & aging.
[57] A. Kertesz,et al. Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia , 2008, Dementia and Geriatric Cognitive Disorders.
[58] E. Finger. New Potential Therapeutic Approaches in Frontotemporal Dementia: Oxytocin, Vasopressin, and Social Cognition , 2011, Journal of Molecular Neuroscience.
[59] M. Freedman,et al. Frontotemporal lobar degeneration , 1998, Neurology.
[60] Jordan Grafman,et al. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia , 2006, Neurology.
[61] J. Morris,et al. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias. , 2007, Archives of neurology.
[62] F. Sherriff,et al. Memantine for dementia. , 2005, The Cochrane database of systematic reviews.
[63] A. Bava,et al. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patients , 2003, American journal of Alzheimer's disease and other dementias.
[64] E. Coccaro,et al. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. , 1998, Archives of general psychiatry.
[65] A. Mackinnon,et al. AVPR1A and OXTR polymorphisms are associated with sexual and reproductive behavioral phenotypes in humans , 2007, Human mutation.
[66] K. Rankin,et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. , 2011, The Journal of clinical psychiatry.
[67] H. Kazui,et al. [Care for patients with Pick's disease--by using their preserved procedural memory]. , 1995, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.
[68] Olivier Piguet,et al. Eating Disturbance in Behavioural-Variant Frontotemporal Dementia , 2011, Journal of Molecular Neuroscience.
[69] Maria Luisa Gorno-Tempini,et al. Structural anatomy of empathy in neurodegenerative disease. , 2006, Brain : a journal of neurology.
[70] Nathaniel Mercaldo,et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. , 2008, Brain : a journal of neurology.
[71] B Miller,et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.
[72] F. Collette,et al. A comparison of unawareness in frontotemporal dementia and Alzheimer’s disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[73] C. Volteau,et al. Memantine in behavioral variant frontotemporal dementia: negative results. , 2011, Journal of Alzheimer's disease : JAD.
[74] R. Curtis,et al. Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. , 2000, Journal of clinical psychopharmacology.